​

Exhibit 10.1

​

*Portions of the exhibit have been excluded because it is both not material and is the type of information that the registrant treats as private or confidential.

​

LICENSE AGREEMENT

​

THIS LICENSE AGREEMENT (the "Agreement") is made as of this 14th day of May, 2026 (the "Effective Date"), between ARE-SD REGION NO. 39 OWNER, LLC, a Delaware limited liability company ("Licensor"), and CAPRICOR THERAPEUTICS, INC., a Delaware corporation ("Licensee").

​

RECITALS:

​

A.Licensor is the owner of that certain 3-story building with 1 subterranean level, containing approximately 171,001 rentable square feet, commonly known as 9625 Towne Centre Drive, San Diego, California ("Building"), which is part of that certain project comprised of approximately 7.48 acres of land, together with all improvements thereon and appurtenances thereto, as described on Exhibit A (the "Project").

​

B.Licensee desires to have a temporary license to use the entire Building, as shown on

…

​

*Portions of the exhibit have been excluded because it is both not material and is the type of information that the registrant treats as private or confidential.

​

LEASE AGREEMENT

​

THIS LEASE AGREEMENT (this “Lease”) is made this *  9  *  day of July, 2026 (the “Effective Date”), between ARE-SD REGION NO. 39 OWNER, LLC, a Delaware limited liability company (“Landlord”), and CAPRICOR THERAPEUTICS, INC., a Delaware corporation (“Tenant”).

​

BASIC LEASE PROVISIONS

​

Building:	9625 Towne Centre Drive, San Diego, California

​

…

​

Exhibit 10.47

**CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED AND REPLACED WITH “[***]”. SUCH IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS (i) NOT MATERIAL AND (ii) **THE REGISTRANT CUSTOMARILY AND ACTUALLY TREATS THAT INFORMATION AS PRIVATE OR CONFIDENTIAL.

​

LOAN AND SECURITY AGREEMENT

Dated as of August 11, 2026

among

ELUTIA INC.,

a Delaware corporation

(“Parent”),

and

ELUTIA MED LLC,

a Delaware limited liability company

(“Elutia Med”; and together with Parent, jointly and severally, individually and collectively, “Borrower”)

and

AVENUE VENTURE OPPORTUNITIES FUND II, L.P.,

a Delaware limited partnership

(as administrative agent and collateral agent (in such capacity “Agent”)

and

AVENUE VENTURE OPPORTUNITIES FUND II, L.P.,

a Delaware limited partnership, (“Avenue 2”)

as a lender

and

AVENUE GROWTH LENDING FUND III, L.P.,

a Delaware limited partnership (“Avenue 3”)

…

​

Exhibit 10.48

**CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED AND REPLACED WITH “[***]”. SUCH IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS (i) NOT MATERIAL AND (ii) **THE REGISTRANT CUSTOMARILY AND ACTUALLY TREATS THAT INFORMATION AS PRIVATE OR CONFIDENTIAL.

SUPPLEMENT

to the

Loan and Security Agreement

dated as of August 11, 2026

among

ELUTIA INC.,

a Delaware corporation,

(“Parent”),

ELUTIA MED LLC,

a Delaware limited liability company

(“Elutia Med”; and together with Parent, jointly and severally, individually and collectively, “Borrower”)

and

AVENUE VENTURE OPPORTUNITIES FUND II, L.P.,

a Delaware limited partnership

(as administrative agent and collateral agent (in such capacity “Agent”)

and

AVENUE VENTURE OPPORTUNITIES FUND II, L.P.,

a Delaware limited partnership (“Avenue 2”)

as a lender

and

AVENUE GROWTH LENDING FUND III, L.P.,

…

TERM SHEET
Strategic Investment into Scilex Holding Company

Date: 3 July 2026

1.

Parties

Investor
iHolding Group LLP
420 Tattimbet Street
Medeu District
Almaty
Republic of Kazakhstan

Company
Scilex Holding Company

2.

Transaction

The Investor agrees to invest the sum of US$100,000,000 into the Company through the acquisition of newly issued equity securities of the Company.

3.

Purchase Price

The investment shall be made at a price of US$15.00 per share. Based upon the investment amount, the Investor shall receive approximately 6,666,667 shares.

4.

Security

The securities issued pursuant to this investment shall consist of newly issued common shares of the Company, unless otherwise mutually agreed in writing between the parties.

5.

Purpose of Investment

−

Expansion of healthcare and medical technology initiatives;

−

Product development and commercialization;

−

Acquisitions and strategic partnerships;

−

Working capital and operational growth;

−

Intellectual property expansion;

−

General corporate purposes.

6.

Scilex Products and Pipeline

…

BINDINGTERMSHEET

DATAVAULTAIINC.–SCILEXHOLDINGCOMPANY

Dated:June24,2026

This binding term sheet (this “Term Sheet”) sets forth the principal terms upon which Scilex Holding Company, a Delaware corporation (“Scilex”), proposes to make cash or Scilex’s common stock or its subsidiaries’ publicly traded securities contributiontoDatavaultAIInc.,aDelawarecorporation(“Datavault”and,togetherwithScilex, the “Parties” and each, a “Party”), in exchange for the Bitcoins (BTC) currently held in Datavault’s Biconomy digital wallet (the “Wallet”), on the terms and subject to the conditions set forth below (the “Transaction”).

…

BINDING TERM SHEET
DATAVAULT AI INC. – SCILEX HOLDING COMPANY

Dated: April 26, 2026

This binding term sheet (this “Term Sheet”) sets forth the principal terms upon which Scilex Holding Company, a Delaware corporation (“Scilex”), proposes to make an upfront cash contribution to Datavault AI Inc., a Delaware corporation (“Datavault” and, together with Scilex, the “Parties” and each, a “Party”), in exchange for the right to receive certain payments tied to revenues generated by Datavault’s quantum-ready edge network, on the terms and subject to the conditions set forth below (the “Transaction”).

…

**ADAMS STREET CREDIT SOLUTIONS FUND **

**AMENDED AND RESTATED MULTIPLE CLASS PLAN **

**ADOPTED PURSUANT TO RULE 18F-3 **

June 2, 2026

WHEREAS, Adams Street Credit Solutions Fund (the “Company”) is a closed-end management investment company that has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended (the “1940 Act”); and

WHEREAS, the Company is permitted to rely on an exemptive order from the Securities and Exchange Commission (the “SEC”) to offer multiple classes of shares (the “Order”); and

WHEREAS, pursuant to the Order, the Company must comply with the provisions of Rule 18f-3 under the 1940 Act as if it were an open-end management investment company; and

WHEREAS, Rule 18f-3 requires that a board of trustees of an investment company desiring to offer multiple classes of shares pursuant to said Rule adopt a plan setting forth the differences among the classes with respect to shareholder services, distribution arrangements, expense allocations and any related conversion features or exchange privileges; and

…

**ADAMS STREET CREDIT SOLUTIONS FUND **

**DISTRIBUTION AND SERVICING PLAN ADOPTED PURSUANT TO RULE 12b-1 **

WHEREAS, Adams Street Credit Solutions Fund (the ”Company”) is a closed-end management investment company that intends to file an election to be regulated as a business development company under the Investment Company Act of 1940, as amended (the ”1940 Act”);

WHEREAS, the Company intends to apply to the Securities and Exchange Commission (the “SEC”) for an exemptive order that would permit the Company to offer multiple classes of common shares of beneficial interest of the Company (the “Shares”) with, among other things, asset-based distribution and/or service fees (the “Order”);

WHEREAS, if granted, reliance on the Order would require the Company to comply with the provisions of Rule 12b-1 under the 1940 Act as if it were an open-end management investment company;

WHEREAS, the Company intends to employ Foreside Fund Services, LLC (“Foreside”) as distributor of the Shares of each Class (as defined below) of the Company; and

…

NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH MAY BE THE LEGAL COUNSEL OPINION (AS DEFINED IN THE PURCHASE AGREEMENT)), IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144, RULE 144A OR REGULATION S UNDER SAID ACT OR OTHER APPLICABLE EXEMPTION. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.

…

THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT.

THE ISSUE PRICE OF THIS NOTE IS $151,800.00

THE ORIGINAL ISSUE DISCOUNT IS $19,800.00

Principal Amount: $151,800.00	Issue Date: July 6, 2026
Purchase Price: $132,000.00	​

​

PROMISSORY NOTE

…

​

Exhibit 10.9

THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT.

THE ISSUE PRICE OF THIS NOTE IS $151,800.00

THE ORIGINAL ISSUE DISCOUNT IS $19,800.00

Principal Amount: $151,800.00	Issue Date: May 5, 2026
Purchase Price: $132,000.00	​

​

PROMISSORY NOTE

…